1-209638541-T-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000228.3(LAMB3):​c.291A>C​(p.Ser97Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.613 in 1,601,282 control chromosomes in the GnomAD database, including 308,745 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. S97S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.56 ( 25024 hom., cov: 32)
Exomes 𝑓: 0.62 ( 283721 hom. )

Consequence

LAMB3
NM_000228.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.889

Publications

25 publications found
Variant links:
Genes affected
LAMB3 (HGNC:6490): (laminin subunit beta 3) The product encoded by this gene is a laminin that belongs to a family of basement membrane proteins. This protein is a beta subunit laminin, which together with an alpha and a gamma subunit, forms laminin-5. Mutations in this gene cause epidermolysis bullosa junctional Herlitz type, and generalized atrophic benign epidermolysis bullosa, diseases that are characterized by blistering of the skin. Multiple alternatively spliced transcript variants that encode the same protein have been found for this gene. [provided by RefSeq, Jul 2008]
LAMB3 Gene-Disease associations (from GenCC):
  • junctional epidermolysis bullosa
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
  • junctional epidermolysis bullosa Herlitz type
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, Laboratory for Molecular Medicine
  • junctional epidermolysis bullosa, non-Herlitz type
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Genomics England PanelApp, Ambry Genetics
  • amelogenesis imperfecta type 1A
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • amelogenesis imperfecta type 1
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • generalized junctional epidermolysis bullosa non-Herlitz type
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 1-209638541-T-G is Benign according to our data. Variant chr1-209638541-T-G is described in ClinVar as Benign. ClinVar VariationId is 255592.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.889 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.645 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000228.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LAMB3
NM_000228.3
MANE Select
c.291A>Cp.Ser97Ser
synonymous
Exon 4 of 23NP_000219.2
LAMB3
NM_001017402.2
c.291A>Cp.Ser97Ser
synonymous
Exon 3 of 22NP_001017402.1
LAMB3
NM_001127641.1
c.291A>Cp.Ser97Ser
synonymous
Exon 4 of 23NP_001121113.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LAMB3
ENST00000356082.9
TSL:1 MANE Select
c.291A>Cp.Ser97Ser
synonymous
Exon 4 of 23ENSP00000348384.3
LAMB3
ENST00000367030.7
TSL:1
c.291A>Cp.Ser97Ser
synonymous
Exon 4 of 23ENSP00000355997.3
LAMB3
ENST00000391911.5
TSL:1
c.291A>Cp.Ser97Ser
synonymous
Exon 3 of 22ENSP00000375778.1

Frequencies

GnomAD3 genomes
AF:
0.560
AC:
85028
AN:
151932
Hom.:
25022
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.420
Gnomad AMI
AF:
0.752
Gnomad AMR
AF:
0.503
Gnomad ASJ
AF:
0.675
Gnomad EAS
AF:
0.276
Gnomad SAS
AF:
0.482
Gnomad FIN
AF:
0.718
Gnomad MID
AF:
0.723
Gnomad NFE
AF:
0.650
Gnomad OTH
AF:
0.574
GnomAD2 exomes
AF:
0.568
AC:
142705
AN:
251300
AF XY:
0.574
show subpopulations
Gnomad AFR exome
AF:
0.410
Gnomad AMR exome
AF:
0.444
Gnomad ASJ exome
AF:
0.680
Gnomad EAS exome
AF:
0.286
Gnomad FIN exome
AF:
0.702
Gnomad NFE exome
AF:
0.656
Gnomad OTH exome
AF:
0.599
GnomAD4 exome
AF:
0.619
AC:
896976
AN:
1449232
Hom.:
283721
Cov.:
31
AF XY:
0.617
AC XY:
445418
AN XY:
721706
show subpopulations
African (AFR)
AF:
0.411
AC:
13652
AN:
33246
American (AMR)
AF:
0.448
AC:
20014
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.681
AC:
17740
AN:
26056
East Asian (EAS)
AF:
0.291
AC:
11534
AN:
39658
South Asian (SAS)
AF:
0.498
AC:
42859
AN:
85998
European-Finnish (FIN)
AF:
0.706
AC:
37731
AN:
53406
Middle Eastern (MID)
AF:
0.674
AC:
3870
AN:
5738
European-Non Finnish (NFE)
AF:
0.649
AC:
713892
AN:
1100440
Other (OTH)
AF:
0.595
AC:
35684
AN:
59986
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
15853
31706
47558
63411
79264
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18404
36808
55212
73616
92020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.559
AC:
85069
AN:
152050
Hom.:
25024
Cov.:
32
AF XY:
0.559
AC XY:
41557
AN XY:
74324
show subpopulations
African (AFR)
AF:
0.420
AC:
17407
AN:
41470
American (AMR)
AF:
0.502
AC:
7675
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.675
AC:
2341
AN:
3468
East Asian (EAS)
AF:
0.276
AC:
1428
AN:
5170
South Asian (SAS)
AF:
0.483
AC:
2327
AN:
4814
European-Finnish (FIN)
AF:
0.718
AC:
7583
AN:
10562
Middle Eastern (MID)
AF:
0.705
AC:
206
AN:
292
European-Non Finnish (NFE)
AF:
0.650
AC:
44209
AN:
67966
Other (OTH)
AF:
0.572
AC:
1209
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1843
3686
5529
7372
9215
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
722
1444
2166
2888
3610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.615
Hom.:
43973
Bravo
AF:
0.536
Asia WGS
AF:
0.390
AC:
1355
AN:
3478
EpiCase
AF:
0.644
EpiControl
AF:
0.650

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Junctional epidermolysis bullosa, non-Herlitz type Benign:1
Jul 08, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Amelogenesis imperfecta type 1A Benign:1
Jul 08, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Junctional epidermolysis bullosa gravis of Herlitz Benign:1
Jul 08, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Junctional epidermolysis bullosa Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
4.3
DANN
Benign
0.50
PhyloP100
-0.89
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2076356; hg19: chr1-209811886; COSMIC: COSV61915034; API